NeilDavidPalmisianoMDMS
Oncology • Philadelphia, PAHematologic Oncology
Associate Professor of Medical Oncology
Dr. Palmisiano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
925 Chestnut St
Ste 320A
Philadelphia, PA 19107Phone+1 215-955-8874Fax+1 215-955-2340
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2011 - 2014- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2008 - 2011
Lewis Katz School of Medicine at Temple UniversityClass of 2008
Certifications & Licensure
NJ State Medical License 2018 - 2025
PA State Medical License 2008 - 2024
DE State Medical License 2018 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy Start of enrollment: 2013 Jul 08
- Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL) Start of enrollment: 2016 Mar 01
- Venetoclax and Vincristine Liposomal in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia Start of enrollment: 2018 Aug 13
- Join now to see all
Publications & Presentations
PubMed
- 87 citationsOutcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remissionArmin Rashidi, Mehdi Hamadani, Mei-Jie Zhang, Hai-Lin Wang, Hisham Abdel-Azim
Blood Advances. 2019-06-25 - 2 citationsA Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation.Dolores Grosso, Benjamin Leiby, Lindsay Wilde, Matthew Carabasi, Joanne Filicko-O'Hara
Transplantation and Cellular Therapy. 2022-12-01 - 13 citationsAn adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.Antonio M. Jimenez, Marcos de Lima, Krishna V. Komanduri, Trent P Wang, Mei-Jie Zhang
Bone Marrow Transplantation. 2021-09-28
Abstracts/Posters
- Single Cell DNA Sequencing Identifies Combinatorial Mutation Patterns and Clonal Architecture in Myeloid MalignanciesNeil Palmisiano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- OPB-111077 in Combination with Decitabine and Venetoclax for the Treatment of Acute Myeloid LeukemiaNeil Palmisiano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Authored Content
- IDH Mutated AML: Beyond Enasidenib and Ivosidenib Monotherapy at SOHO 2021September 2021
Press Mentions
Neil Palmisiano, MD, Appointed as Deputy Director of Phase 1 Therapeutics for Hematologic Malignancies at Rutgers Cancer Institute of New JerseyOctober 3rd, 2022- ASH 2023: Tailoring Treatment in AMLDecember 22nd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
